|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Descriptive Information Fields | |
| Brief Title † | Ondansetron Treatment for Alcoholism |
| Official Title † | Pharmacological Treatment for Alcoholism |
| Brief Summary | The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program. |
| Detailed Description | |
| Study Phase | Phase II |
| Study Type † | Interventional |
| Study Design † | Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study |
| Primary Outcome Measure † | |
| Secondary Outcome Measure † | |
| Condition † | Alcoholism |
| Intervention † | Drug: ondansetron (Zofran) |
| MEDLINE PMIDs | |
| Links | |
| Recruitment Information Fields | |
| Recruitment Status † | Completed |
| Enrollment † | |
| Start Date † | |
| Completion Date | April 2000 |
| Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Both |
| Ages | 25 Years to 60 Years |
| Accepts Healthy Volunteers | No |
| Contacts †† | |
| Location Countries † | United States |
| Administrative Information Fields | |
| NCT ID † | NCT00000443 |
| Organization ID | NIAAAJOH10522 |
| Secondary IDs †† | |
| Study Sponsor † | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Collaborators †† | |
| Investigators † | |
| Information Provided By | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Verification Date | August 2002 |
| First Received Date † | November 2, 1999 |
| Last Updated Date | June 23, 2005 |